Epi proColon

DEVICE2 trials

Sponsors

Epigenomics, Inc

Conditions

Colo-rectal CancerColorectal CancerColorectal Neoplasms

Unknown Phase

Longitudinal Performance of Epi proColon

Epigenomics, IncColorectal Cancer, Colorectal Neoplasms

Start: 2017-08-18End: 2024-01-31Target: 4500Updated: 2021-11-01

Plasma-based Colorectal Cancer Screening Research & Development

CompletedNCT04027790

Epigenomics, IncColo-rectal Cancer

Start: 2019-05-03End: 2020-03-31Updated: 2021-02-02